Cargando…

Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity

Serotonin (5-hydroxytryptamine [5-HT]) is a monoamine that has various functions in both neuronal and non-neuronal systems. In the central nervous system, 5-HT regulates mood and feeding behaviors as a neurotransmitter. Thus, there have been many trials aimed at increasing the activity of 5-HT in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Chang-Myung, Park, Sangkyu, Kim, Hail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Diabetes Association 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853228/ https://www.ncbi.nlm.nih.gov/pubmed/27126880 http://dx.doi.org/10.4093/dmj.2016.40.2.89

Ejemplares similares

Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
por: Shong, Ko Eun, et al.
Publicado: (2020)

Erratum: Correction of Figure. Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
por: Shong, Ko Eun, et al.
Publicado: (2020)

Peripheral Serotonin: a New Player in Systemic Energy Homeostasis
por: Namkung, Jun, et al.
Publicado: (2015)

Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance
por: Namkung, Jun, et al.
Publicado: (2018)

Serotonin in the regulation of systemic energy metabolism
por: Moon, Joon Ho, et al.
Publicado: (2022)

Regulation of systemic energy homeostasis by serotonin in adipose tissues
por: Oh, Chang-Myung, et al.
Publicado: (2015)

A Systems Biology Approach to Investigating the Interaction between Serotonin Synthesis by Tryptophan Hydroxylase and the Metabolic Homeostasis
por: Park, Suhyeon, et al.
Publicado: (2021)

Serotonin and Its Receptor as a New Antioxidant Therapeutic Target for Diabetic Kidney Disease
por: Yang, Yu, et al.
Publicado: (2017)

Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity
por: El husseny, Mostafa Wanees Ahmed, et al.
Publicado: (2017)

Epigenetics in Obesity and Diabetes Mellitus: New Insights
por: Suárez, Rosario, et al.
Publicado: (2023)

The Serotonin-6 Receptor as a Novel Therapeutic Target
por: Yun, Hyung-Mun, et al.
Publicado: (2011)

Diabetes Mellitus and Obesity
Publicado: (1935)

Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
por: Lee, Ansoo, et al.
Publicado: (2022)

Novel targets for potential therapeutic use in Diabetes mellitus
por: Dhankhar, Sanchit, et al.
Publicado: (2023)

Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Choi, Wonsuk, et al.
Publicado: (2018)

TRP Channels as Therapeutic Targets in Diabetes and Obesity
por: Zsombok, Andrea, et al.
Publicado: (2016)

Serotonergic Regulation of Hepatic Energy Metabolism
por: Park, Jiwon, et al.
Publicado: (2021)

Anthocyanins: Potential Therapeutic Approaches towards Obesity and Diabetes Mellitus Type 2
por: Franco-San Sebastián, Denise, et al.
Publicado: (2023)

Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity
por: Vasincu, Alexandru, et al.
Publicado: (2023)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Publisher Correction: Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Choi, Wonsuk, et al.
Publicado: (2019)

Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus
por: Islam, Fahadul, et al.
Publicado: (2022)

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
por: Achari, Arunkumar E., et al.
Publicado: (2017)

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
por: Su, Jingqian, et al.
Publicado: (2023)

The Role of Serotonin in Ventricular Repolarization in Pregnant Mice
por: Cui, Shanyu, et al.
Publicado: (2018)

In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins
por: Kurylowicz, Alina
Publicado: (2016)

Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia
por: Tsegay, Etsay Weldekidan, et al.
Publicado: (2020)

Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications
por: Naseri, Rozita, et al.
Publicado: (2020)

Mechanism linking diabetes mellitus and obesity
por: Al-Goblan, Abdullah S, et al.
Publicado: (2014)

Leptin, adiponectin and serotonin levels in lean and obese dogs
por: Park, Hyung-Jin, et al.
Publicado: (2014)

RANKL inhibition: a new target of treating diabetes mellitus?
por: Xing, Baodi, et al.
Publicado: (2023)

Assessment HOMA as a predictor for new onset diabetes mellitus and diabetic complications in non-diabetic adults: a KoGES prospective cohort study
por: Lee, Jibeom, et al.
Publicado: (2023)

Case report: Magnesium—A new therapeutic target in gestational diabetes mellitus?
por: Zhang, Kun
Publicado: (2020)

Diabetic Neuropathic Pain and Serotonin: What Is New in the Last 15 Years?
por: Mokhtar, Nazarine, et al.
Publicado: (2023)

Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus
por: Cheng, Long, et al.
Publicado: (2021)

A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
por: Jung, Chang Hee, et al.
Publicado: (2014)

Epigenetic modification and therapeutic targets of diabetes mellitus
por: Singh, Rajveer, et al.
Publicado: (2020)

In silico structure-based designers of therapeutic targets for diabetes mellitus or obesity: A protocol for systematic review
por: Gomes, Ana Francisca Teixeira, et al.
Publicado: (2022)

Exercise intervention under hypoxic condition as a new therapeutic paradigm for type 2 diabetes mellitus: A narrative review
por: Kim, Sung-Woo, et al.
Publicado: (2021)

Therapeutic Phytogenic Compounds for Obesity and Diabetes
por: Jung, Hee Soong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_70incah6s8ni7hvfeg0mhlhh8t